For the first time since 1998, the U.S. Food and Drug Administration is expected to review the nutrients and other ingredients in formula.

FDA outlines both short-term and long-term goals within the letter. In the short term, FDA plans to create a “centralized, ...

Shares of Abbott Laboratories ABT slipped 2.71% to $133.67 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.80% to ...

Dr. Aziz Rahman, an American intensive care specialist working at the Nasser Hospital in Khan Younis, appealed for international assistance with the critical lack of formula for malnourished ...

Abbott Laboratories (ABT) is currently at $138.45, up $5.19 or 3.89% --Would be highest close since March 3, 2025, when it closed at $140.22 --On pace for largest percent increase since Jan. 23 ...

Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's ...

Mead Johnson’s planned expansion of its baby formula and nutritional products plant in Zeeland has stalled amid pushback from residents.

All lots of Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs, and Orajel Baby Teething Swabs have been recalled.

Why is the government reviewing baby formula now? Kennedy announced the review of infant formula in March as part of his “Make America Healthy Again” agenda for the U.S. food supply.